Re-Enjoying Life’s Simple Pleasures
Standing. Walking. Bathing. Sleeping. While these essential, everyday activities are simple pleasures for most people, they can be monumental tasks for patients with chronic venous disease.
enVVeno Medical creates first-in-class, innovative medical devices with potential to set new standards of care for the treatment of venous disease. Our goal is to improve the lives of venous disease patients and to transform what have become monumental, everyday tasks, back into life’s simple pleasures.
enVVeno Medical (Nasdaq: NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in the treatment of venous disease. The Company’s lead product, the VenoValve®, is a first-in-class implant being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). In healthy patients, valves inside the veins of the leg assist in propelling blood up the leg, and back to the heart and lungs. Affecting approximately 2.4 million people in the United States, CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Implanted into the femoral vein, the VenoValve is designed to act as a one-way valve, to help restore proper blood flow in the leg.
SAVVE Clinical Study